- Published at
- by seekingalpha.com
positive
positive
BridgeBio spinout to go public in SPAC deal (HLXB:NASDAQ)
BridgeBio Pharma (BBIO) stock in focus as its 2024 spinout BridgeBio Oncology merges with Helix to form go public on Nasdaq under the ticker symbol BBOT. Read more here.